HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Avindra Nath Selected Research

Neurologic Manifestations (Neurological Manifestations)

10/2017Therapeutic Approaches for Zika Virus Infection of the Nervous System.
10/2016HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy.
8/2013Retroviruses and amyotrophic lateral sclerosis.
3/2011Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Avindra Nath Research Topics

Disease

41HIV Infections (HIV Infection)
10/2022 - 01/2003
30Infections
10/2023 - 09/2003
22AIDS Dementia Complex
12/2013 - 06/2003
15Multiple Sclerosis
11/2022 - 02/2006
14Acquired Immunodeficiency Syndrome (AIDS)
01/2021 - 01/2003
12Cognitive Dysfunction
01/2023 - 01/2006
12Neurocognitive Disorders (Clerambault Syndrome)
01/2022 - 05/2008
12Dementia (Dementias)
01/2018 - 10/2003
11Encephalitis (Encephalitis, Rasmussen)
01/2022 - 05/2004
9Progressive Multifocal Leukoencephalopathy
01/2021 - 04/2010
8Neoplasms (Cancer)
04/2024 - 05/2005
8Inflammation (Inflammations)
04/2024 - 02/2004
7Neuroinflammatory Diseases
02/2019 - 12/2004
6Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2024 - 09/2015
6COVID-19
01/2023 - 01/2020
6Nervous System Diseases (Neurological Disorders)
10/2014 - 01/2004
6Substance-Related Disorders (Drug Abuse)
09/2010 - 06/2004
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 03/2007
5Opportunistic Infections (Opportunistic Infection)
10/2016 - 05/2008
5Immune Reconstitution Inflammatory Syndrome
11/2014 - 10/2006
4Alzheimer Disease (Alzheimer's Disease)
11/2019 - 01/2003
4Neurologic Manifestations (Neurological Manifestations)
10/2017 - 03/2011
3Glioblastoma (Glioblastoma Multiforme)
04/2024 - 01/2022
3Fatigue
02/2024 - 01/2023
3Brain Diseases (Brain Disorder)
01/2022 - 05/2004
3Central Nervous System Diseases (CNS Diseases)
12/2014 - 03/2005
2Glioma (Gliomas)
04/2024 - 01/2009
2Atrophy
01/2023 - 01/2020
2Nodding Syndrome
01/2023 - 01/2017
2Disease Progression
10/2022 - 11/2019
2Carcinogenesis
01/2021 - 01/2021
2Body Weight (Weight, Body)
01/2019 - 01/2002
2Virus Diseases (Viral Diseases)
01/2018 - 04/2017
2Leukocytosis (Pleocytosis)
04/2013 - 11/2012
2Vascular Remodeling
01/2008 - 09/2005
2Gliosis
10/2003 - 09/2003
1Proteostasis Deficiencies
05/2024

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2003
8Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2004
6AntibodiesIBA
01/2024 - 01/2003
6Opiate AlkaloidsIBA
01/2009 - 04/2005
5ChemokinesIBA
01/2023 - 06/2003
5Peptides (Polypeptides)IBA
11/2022 - 08/2014
5Natalizumab (Tysabri)FDA Link
01/2021 - 04/2010
5Viral ProteinsIBA
01/2021 - 12/2004
5Amyloid (Amyloid Fibrils)IBA
10/2019 - 01/2003
5Human Immunodeficiency Virus tat Gene ProductsIBA
11/2014 - 04/2003
5tat Gene Products (tat Protein)IBA
10/2009 - 09/2003
4VaccinesIBA
10/2023 - 01/2003
4Adrenal Cortex Hormones (Corticosteroids)IBA
11/2021 - 06/2011
4LipidsIBA
01/2020 - 02/2004
4Human Immunodeficiency Virus ProteinsIBA
04/2007 - 08/2004
3CytokinesIBA
01/2023 - 03/2006
3Fluconazole (Zonal)FDA LinkGeneric
01/2022 - 12/2014
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 08/2004
3Apolipoproteins E (ApoE)IBA
09/2011 - 08/2004
3SphingolipidsIBA
11/2008 - 02/2004
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2007 - 01/2004
3Estrogens (Estrogen)FDA Link
04/2006 - 07/2004
2Protease Inhibitors (Protease Inhibitor)IBA
04/2024 - 12/2020
2Reverse Transcriptase InhibitorsIBA
04/2024 - 03/2007
2IronIBA
01/2024 - 01/2008
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2023 - 01/2022
2RNA (Ribonucleic Acid)IBA
01/2023 - 01/2023
2Retinaldehyde (Retinal)IBA
10/2022 - 01/2008
2ElementsIBA
01/2022 - 01/2021
2Anti-Bacterial Agents (Antibiotics)IBA
12/2020 - 01/2003
2Peptide Hydrolases (Proteases)FDA Link
12/2020 - 02/2004
2Chloroquine (Aralen)FDA LinkGeneric
01/2020 - 11/2008
2Protons (Proton)IBA
02/2019 - 09/2007
2Inositol (Myoinositol)IBA
01/2019 - 12/2004
2Insulin (Novolin)FDA Link
01/2019 - 04/2015
2CreatineIBA
01/2019 - 12/2004
2Glutamic Acid (Glutamate)FDA Link
01/2019 - 04/2007
2pembrolizumabIBA
01/2019 - 01/2019
2Paroxetine (Paxil)FDA LinkGeneric
01/2018 - 12/2014
2GadoliniumIBA
04/2017 - 08/2008
2AutoantibodiesIBA
01/2017 - 01/2003
2AntigensIBA
01/2017 - 01/2009
2Immunomodulating AgentsIBA
12/2015 - 12/2012
2Neurotransmitter Agents (Neurotransmitter)IBA
12/2014 - 03/2005
2ProteomeIBA
12/2013 - 06/2012
2Viral RNAIBA
09/2013 - 03/2005
2Immunoglobulin G (IgG)IBA
10/2011 - 10/2010
2Morphine (MS Contin)FDA LinkGeneric
11/2008 - 10/2008
2Crystallins (Crystallin)IBA
01/2008 - 09/2005
2Memantine (Namenda)FDA Link
09/2007 - 08/2006
2Methamphetamine (Desoxyn)FDA LinkGeneric
05/2007 - 02/2004
2AntioxidantsIBA
11/2006 - 12/2005
2ApolipoproteinsIBA
07/2006 - 08/2004
2Transcription Factors (Transcription Factor)IBA
12/2004 - 01/2004
2CeramidesIBA
12/2004 - 02/2004
1DNA-Binding Proteins (DNA Binding Protein)IBA
05/2024
1Antineoplastic Agents (Antineoplastics)IBA
04/2024

Therapy/Procedure

41Therapeutics
04/2024 - 01/2003
12Highly Active Antiretroviral Therapy (HAART)
01/2021 - 12/2004
5Art Therapy
04/2024 - 08/2013
5Immunomodulation
01/2023 - 04/2006
4Immunotherapy
01/2023 - 07/2012
2Drug Therapy (Chemotherapy)
04/2024 - 02/2015